Back

Role of GLP1a drugs after TAVI: insights from the MOTIVE registry

30 August 2026 (16:15 - 17:00)
Organised by: Logo
Congress Presentation Part of: Determinants of outcomes in structural and coronary interventions: from trials to real-world data Aortic Valve Intervention ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Marco Balducci

Hospital Citta Della Salute e della Scienza di Torino, Turin (Italy)

6 More presentations in this session

Presentation thumbnail
Early health-status improvement after transcatheter tricuspid edge-to-edge repair predicts long-term reduction in heart-failure hospitalizations: insights from theTRI-FR randomized trial
Professor E. Donal (Rennes, FR)
Abstract Slides Video
Presentation thumbnail
Mortality in patients with mild and moderate paravalvular leakage after transcatheter aortic valve implantation
Ms E. Lofgren (Uppsala, SE)
Abstract Slides Video
Presentation thumbnail
Frailty and outcomes after percutaneous coronary intervention: a systematic review and dose–response meta-analysis
Doctor N. Khan (Peshawar, PK)
Abstract Slides Video
Presentation thumbnail
Atrial versus ventricular secondary tricuspid regurgitation in patients undergoing tricuspid transcatheter edge-to-edge repair: a two-centre european cohort study
Doctor J. Martin Diaz (Cordoba, ES)
Abstract Slides Video
Presentation thumbnail
Premature coronary artery disease and 1-year outcomes after PCI
Ms S. Janssen (Heerlen, NL)
Abstract Slides Video

Access the full session

Session thumbnail
Determinants of outcomes in structural and coronary interventions: from trials to real-world data

The Event

Event poster

ESC Congress 2026

30 August 2026 16:15 CET
You may be interested in
thumbnail
Congress Presentation
Association of SGLT2-inhibitor and GLP1-receptor agonist use with clinical outcomes in aortic stenosis: a large-scale propensity-matched study
28 August 2026
thumbnail
Congress Presentation
Glucagon-like peptide-1 receptor agonists and outcomes in heart failure with preserved ejection fraction and obesity: a real-world systematic review and meta-analysis of observational studies
28 August 2026
thumbnail
Congress Presentation
Effect of glucagon-like peptide-1 agonists on ventricular tachycardia ablation outcomes
1 September 2025
thumbnail
Congress Presentation
Impact of chronic GLP-1 receptor agonist and SGLT-2 inhibitor therapy on in-hospital outcomes of patients with diabetes mellitus hospitalized with acute myocardial infarction.
28 August 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources